Cargando…
Biomarkers of lung cancer for screening and in never-smokers—a narrative review
BACKGROUND AND OBJECTIVE: Lung cancer is the leading cause of cancer-related mortality worldwide, partially attributed to late-stage diagnoses. In order to mitigate this, lung cancer screening (LCS) of high-risk patients is performed using low dose computed tomography (CT) scans, however this method...
Autores principales: | Stephens, Edward K. H., Guayco Sigcha, Jazmin, Lopez-Loo, Kenneth, Yang, Ian A., Marshall, Henry M., Fong, Kwun M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10654441/ https://www.ncbi.nlm.nih.gov/pubmed/38025810 http://dx.doi.org/10.21037/tlcr-23-291 |
Ejemplares similares
-
Small-cell lung cancer in never-smokers
por: Torres-Durán, M., et al.
Publicado: (2021) -
Serum biomarkers of polyomavirus infection and risk of lung cancer in never smokers
por: Malhotra, Jyoti, et al.
Publicado: (2016) -
Genetic differences between smokers and never-smokers with lung cancer
por: Kuśnierczyk, Piotr
Publicado: (2023) -
Narrative review: association between lung cancer development and ambient particulate matter in never-smokers
por: Lim, Jeong Uk, et al.
Publicado: (2022) -
Distinct immune microenvironment of lung adenocarcinoma in never-smokers from smokers
por: Luo, Wenxin, et al.
Publicado: (2023)